Literature DB >> 509355

Action of galactose oxidase on galactolipids.

C A Lingwood.   

Abstract

Exposure of galactose-containing glycosphingolipids and certain glycoproteins to galactose oxidase followed by treatment with sodium borotritide has been used to label specifically the terminal galactose and N-acetylgalactosamine moieties of these glycoconjugates. This labelling procedure was shown to be ineffective with a lipid isolated from rat testis, 1-O-palmityl-2-O-palmitoyl-3 beta-galactosyl-glycerol, under conditions which resulted in excellent labelling of galactosyl-ceramide. Monogalactosyldiacylglycerol was also poorly labelled by this procedure. It was shown that neither 1-O-palmityl-2-O-palmitoyl-3 beta-(3'-sulfogalactosyl)-glycerol nor sulfogalactosyl-ceramide ("classical sulfatide") was labelled by this procedure indicating that sulfate substitution of the galactose inhibits the action of galactose oxidase. The labelling of galactosyl-ceramide was not inhibited in the presence of the galactoglycerolipid, sulfogalactoglycerolipid, or sulfatide. The property of the lipid aglycone responsible for inhibiting galactose oxidase action remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 509355     DOI: 10.1139/o79-146

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  3 in total

Review 1.  Aglycone modulation of glycolipid receptor function.

Authors:  C A Lingwood
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

2.  Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1.

Authors:  R E Willoughby; R H Yolken; R L Schnaar
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

3.  Developmental regulation of galactoglycerolipid and galactosphingolipid sulphation during mammalian spermatogenesis. Evidence for a substrate-selective inhibitor of testicular sulphotransferase activity in the rat.

Authors:  C A Lingwood
Journal:  Biochem J       Date:  1985-10-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.